Pamatolol

CAS: 59110-35-9

Ref. 3D-JCA11035

Información del producto

• Nombre: Pamatolol
• Sinónimos: (2-(4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)phenyl) ethyl)carbamic acid methyl ester, Carbamic acid, N-[2-[4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]ethyl]-, methyl ester, Carbamic acid, [2-[4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]ethyl]-, methyl ester, Methyl ( -)-4-(2-hydroxy-3-(isopropylamino)propoxy)phenethylcarbamat, Methyl (2-{4-[2-Hydroxy-3-(Propan-2-Ylamino)Propoxy]Phenyl}Ethyl)Carbamate, Methyl N-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenethyl)carbamat, Pamatolol [INN], Pamatololum, Pamatololum [INN-Latin], Unii-20G2S6V53L

Descripción

Pamatolol is a beta-blocker that is used in the treatment of high blood pressure and heart disease. It has been shown to inhibit the production of fatty acids in rat liver microsomes, which may play an important role in cancer. Pamatolol has also been shown to have anti-inflammatory effects and to inhibit the production of cytokines, such as IL-1β, IL-6, and TNF-α. The drug also inhibits the activity of 2-adrenergic receptors, which are involved in inflammatory bowel disease. This medication does not affect the activity of prostaglandin H synthase (prostaglandin C synthase), which plays an important role in inflammatory bowel disease.
Pamatolol has been shown to be effective against human liver cells, but long-term studies on its toxicity are still required.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 310.39 g/mol
• Fórmula: C₁₆H₂₆N₂O₄
• Pureza: Min. 95%